ALNTY I CMV IGG CTL

  • €106.79
    Unit price per 
Tax included.


ALNTY I CMV IGG CTL - Enhance Immune Response Against Cytomegalovirus

The ALNTY I CMV IGG CTL is a cutting-edge diagnostic tool designed to accurately assess immunity against cytomegalovirus (CMV) infections. Ideal for healthcare professionals and researchers, this product provides crucial insights into the immune status of individuals, supporting timely interventions and effective management of CMV-related health issues.

Key Features & Benefits:
- High Sensitivity and Specificity: The ALNTY I CMV IGG CTL offers exceptional sensitivity and specificity, ensuring accurate detection of CMV immunoglobulin G (IgG) antibodies. This feature empowers healthcare providers to make informed decisions based on reliable test results.
- User-Friendly Format: Designed with convenience in mind, this test kit is straightforward to use, minimizing the complexity of sample collection and analysis. This translates to quicker diagnostics and improved patient care.
- Rapid Turnaround Time: With a fast processing capability, the ALNTY I CMV IGG CTL ensures that results are available promptly, enabling clinicians to initiate timely treatment plans for patients with CMV considerations.
- Comprehensive Guidance Materials: Each kit comes with detailed instructions and guidance for interpreting results, equipping users with the knowledge necessary to accurately assess CMV immune status.

Technical Specifications:
- Model Number: ALNTY-I-CMV-IGG-CTL
- Dimensions: 10 x 5 x 2 inches
- Weight: 0.5 pounds
- Material: High-quality plastic components for durability
- Test Type: Serological assay for IgG antibodies against CMV

Offering robust performance and reliable results, the ALNTY I CMV IGG CTL stands as an essential tool for effective CMV management in clinical and research settings. Trust in this product to enhance your diagnostic capabilities and support better health outcomes for individuals at risk of CMV infections.